Immunotech Laboratories, Inc.
IMMB
Rank in Stocks
#33902
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$115.39K
Change (1 day)
0.00%
Change (1 year)
100.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Immunotech Laboratories, Inc. (IMMB)
Category
Healthcare
EPS for Immunotech Laboratories, Inc. (IMMB)
EPS as of December 2016 TTM: $0.00
According to Immunotech Laboratories, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2016 the company had an EPS of 0.00, equal to its 2013 EPS of 0.00.
EPS history for Immunotech Laboratories, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -35.71% |
| 2016 | 0.00 | -35.71% |
| 2013 | 0.00 | 0.00% |
| 2009 | 0.00 | -100.00% |
| 2005 | $-802.00 | 1,765.12% |
| 2004 | $-43.00 | -78.50% |
| 2003 | $-200.00 | -75.00% |
| 2002 | $-800.00 | 87.94% |
| 2001 | $-425.67 | 87.25% |
| 2000 | $-227.33 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,957,600.00% |
US
|
|
| $-7.07 | 883,650.00% |
US
|
|
| $-5.29 | 661,150.00% |
AU
|
|
| $12.88 | -1,610,112.50% |
BE
|
|
| $21.56 | -2,695,100.00% |
NL
|
Questions about Immunotech Laboratories, Inc.'s earnings per share (EPS)
What is Immunotech Laboratories, Inc.'s earnings per share (EPS)?
Immunotech Laboratories, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Dec 2016.
What was Immunotech Laboratories, Inc.'s earnings per share (EPS) in 2016?
In 2016, Immunotech Laboratories, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2013.
How has Immunotech Laboratories, Inc.'s earnings per share (EPS) changed since 2013?
From 2013 to 2016, Immunotech Laboratories, Inc.'s earnings per share (EPS) was highest in 2016 (0.00) and lowest in 2016 (0.00).
How does Immunotech Laboratories, Inc.'s earnings per share (EPS) compare with similar companies?
Immunotech Laboratories, Inc.'s earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.